ClinicalTrials.Veeva

Menu
S

S-Medicon Kft | Budapest, Hungary

Research site

Site insights

Top conditions

Top treatments

Atogepant
Lu-AG09222
Topiramate

Curious how this site stacks up to its peers?

Data sourced from clinicaltrials.gov

Active trials

5 of 5 total trials

A Dose-finding Trial With Lu-AG09222 in Adults With Migraine Who Have Not Been Helped by Prior Preventive Treatments (PROCEED)

The purpose of this trial is to determine which doses of Lu AG09222 are recommended to help prevent migraines. People who join this trial have alread...

Enrolling
Migraine
Drug: Lu AG09222
Drug: Placebo

This study will evaluate the Long-Term Safety and Tolerability of Atogepant 60 mg daily for the Prevention of Migraine in Participants with Chronic o...

Active, not recruiting
Chronic Migraine
Episodic Migraine
Drug: Atogepant 60 mg
Locations recently updated

A migraine is a moderate to severe headache on one side of the head. A migraine attack is a headache that may be accompanied by throbbing, nausea, vo...

Enrolling
Episodic Migraine
Drug: Placebo-Matching Atogepant
Drug: Atogepant

A migraine is a moderate to severe headache on one side of the head that may be accompanied by throbbing, nausea, vomiting, sensitivity to light and...

Active, not recruiting
Migraine
Drug: Placebo for Atogepant
Drug: Topiramate

A migraine attack is a moderate or severe headache that usually occurs on one side of the head and is often accompanied by throbbing, sensitivity to...

Enrolling
Migraine
Drug: Placebo for Atogepant
Drug: Atogepant

Trial sponsors

AbbVie logo
Lundbeck logo

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems